Richard “Rick” Slayman, the first person to receive a genetically modified pig kidney transplant, passed away on Saturday, May 11th, 2024, approximately two months after the surgery. Neither his family nor Massachusetts General Hospital, where the procedure took place, believe his death is directly related to the transplant.
What is Xenotransplantation?
Xenotransplantation involves transplanting organs, tissues, or cells from animals into humans. This area of medicine holds promise for addressing the organ donor shortage. In the United States alone, nearly 90,000 people await kidney transplants, with thousands dying each year on the waiting list. Xenotransplantation is being explored for other conditions as well, including neurodegenerative diseases and diabetes.
How Does Xenotransplantation Work?
The pig kidney transplanted into Mr. Slayman underwent significant genetic modification to prevent rejection by his body. This involved removing specific pig genes that trigger an immune response and adding human genes to improve compatibility. Additionally, anti-rejection medications are used post-surgery, similar to standard organ transplants.
Why Pigs?
Pig organs are often chosen for xenotransplantation due to their anatomical and physiological similarities to humans. Additionally, pigs are readily available and can be bred to match the size needs of the recipient. However, there are challenges. The first pig heart xenotransplantation in January 2022 resulted in the patient’s death after two months, possibly due to a latent virus in the pig heart.
Complications of Xenotransplantation
A major hurdle in xenotransplantation is preventing organ rejection. Strategies like implanting the pig’s thymus gland alongside the kidney are being explored. Additionally, there’s a risk of infection from unknown pathogens in the animal organ, potentially spreading to the recipient’s contacts or the general population. Another concern is the possibility of cross-species transmission of retroviruses, which can lie dormant for years before causing illness.
After the death of Richard Sleman
It is natural to raise questions on the future of xenotransplantation. This sector is still in a state of development and is facing many challenges. Nevertheless, Sleman’s decision to transplant a pig kidney was a significant accomplishment. This has shown that Xenotransplantation can play an important role in saving human lives in the future.
However, in Slayman’s case, it is unclear whether his death was linked to the transplant. Further research may answer this question. Also, scientists are trying to understand how animal parts can be made better for the human body. For example, genetic changes could be further refined to make organs less likely to be rejected.
Research is also ongoing to reduce the risk of viral infection. This involves inactivating viruses found in pigs or genetically modifying them so that they cannot infect humans.
It is difficult to say how long it will take for xenotransplantation to become widely used. But Sleman’s case reflects progress made in the field and offers hope for reducing organ shortages in the future.